SARS-CoV-2 N-Antigen Quantification in Respiratory Tract, Plasma and Urine: Kinetics and Association with RT-qPCR Results.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
24 04 2023
Historique:
received: 29 03 2023
revised: 13 04 2023
accepted: 17 04 2023
medline: 29 5 2023
pubmed: 27 5 2023
entrez: 27 5 2023
Statut: epublish

Résumé

Qualitative SARS-CoV-2 antigen assays based on immunochromatography are useful for mass diagnosis of COVID-19, even though their sensitivity is poor in comparison with RT-PCR assays. In addition, quantitative assays could improve antigenic test performance and allow testing with different specimens. Using quantitative assays, we tested 26 patients for viral RNA and N-antigen in respiratory samples, plasma and urine. This allowed us to compare the kinetics between the three compartments and to compare RNA and antigen concentrations in each. Our results showed the presence of N-antigen in respiratory (15/15, 100%), plasma (26/59, 44%) and urine (14/54, 28.9%) samples, whereas RNA was only detected in respiratory (15/15, 100%) and plasma (12/60, 20%) samples. We detected N-antigen in urine and plasma samples until the day 9 and day 13 post-inclusion, respectively. The antigen concentration was found to correlate with RNA levels in respiratory (

Identifiants

pubmed: 37243128
pii: v15051041
doi: 10.3390/v15051041
pmc: PMC10221862
pii:
doi:

Substances chimiques

RNA, Viral 0
Blood Group Antigens 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

J Infect Dis. 2022 Sep 13;226(5):812-821
pubmed: 35230450
N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
Respir Med. 2006 May;100(5):884-91
pubmed: 16226441
Ann Intern Med. 2022 Oct;175(10):1401-1410
pubmed: 36037469
Viruses. 2020 Dec 10;12(12):
pubmed: 33322035
Diagn Microbiol Infect Dis. 2011 Dec;71(4):467-9
pubmed: 21996098
J Infect. 2022 Mar;84(3):418-467
pubmed: 34953907
J Med Virol. 2021 Feb;93(2):719-725
pubmed: 32706393
Cochrane Database Syst Rev. 2020 Aug 26;8:CD013705
pubmed: 32845525
Crit Care. 2022 Sep 14;26(1):278
pubmed: 36104754
Clin Microbiol Infect. 2020 Dec 8;:
pubmed: 33307227
Int J Infect Dis. 2021 Dec;113:113-115
pubmed: 34597768
JAMA. 2020 May 12;323(18):1843-1844
pubmed: 32159775
J Clin Med. 2020 Jun 16;9(6):
pubmed: 32560044
Diagnostics (Basel). 2021 Jul 26;11(8):
pubmed: 34441280
Diagnostics (Basel). 2021 Jan 01;11(1):
pubmed: 33401392
Clin Chem. 2021 Dec 30;68(1):204-213
pubmed: 34605900

Auteurs

Delphine Parraud (D)

Laboratoire de Virologie, Institut des Agents Infectieux, Laboratoire Associé Au Centre National de Référence des Virus des Infections Respiratoires, Hospices Civils de Lyon, F-69317 Lyon, France.

Anne-Lise Maucotel (AL)

Laboratoire de Virologie, Institut des Agents Infectieux, Laboratoire Associé Au Centre National de Référence des Virus des Infections Respiratoires, Hospices Civils de Lyon, F-69317 Lyon, France.

Maude Bouscambert (M)

CIRI, Centre International de Recherche en Infectiologie, Team VirPath, Univ Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, F-69007 Lyon, France.

Florence Morfin (F)

CIRI, Centre International de Recherche en Infectiologie, Team VirPath, Univ Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, F-69007 Lyon, France.

Laurent Bitker (L)

Service de Médecine Intensive-Réanimation, Hôpital de la Croix Rousse, Hospices Civils de Lyon, 103 Grande Rue de la Croix Rousse, CEDEX 04, F-69317 Lyon, France.

Christian Chidiac (C)

Service des Maladies Infectieuses et Tropicales, Hospices Civils de Lyon, Groupement Hospitalier Nord, Université Claude Bernard Lyon 1, F-69317 Lyon, France.

Nathalie De Castro (N)

Service des Maladies Infectieuses et Tropicales, Hôpital Saint-Louis, APHP, F-75010 Paris, France.

Emilie Frobert (E)

CIRI, Centre International de Recherche en Infectiologie, Team VirPath, Univ Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, F-69007 Lyon, France.

Alexandre Gaymard (A)

CIRI, Centre International de Recherche en Infectiologie, Team VirPath, Univ Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, F-69007 Lyon, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH